Cancer-Focused Biotech Lands $79.5M Series B Round
Oncorus, a biotechnology company focused on cancer treatments, on Wednesday said it landed $79.5 million in its latest funding round, which will be used to advance its lead drug candidate to...To view the full article, register now.
Already a subscriber? Click here to view full article